The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
23777782 |
107 |
Orally available and efficaciousa4ß1/a4ß7 integrin inhibitors. |
Elan Pharmaceuticals |
23562062 |
4 |
Arylsulfonamide pyrimidines as VLA-4 antagonists. |
Elan Pharmaceuticals |
23312474 |
36 |
Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4-beta1 and alpha4-beta7 receptor antagonists. |
Hoffmann-La Roche |
23312471 |
31 |
Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual actinga4ß1 anda4ß7 receptor antagonists. |
Hoffmann-La Roche |
18331794 |
20 |
Selective cell adhesion inhibitors: Barbituric acid based alpha4beta7--MAdCAM inhibitors. |
Millennium Pharmaceuticals |
18226905 |
60 |
Synthesis and SAR of pyridazinone-substituted phenylalanine amide alpha4 integrin antagonists. |
Johnson & Johnson Pharmaceutical Research & Development |
12139455 |
78 |
Selective alpha4beta7 integrin antagonists and their potential as antiinflammatory agents. |
Genentech |
17118652 |
15 |
Highly constrained bicyclic VLA-4 antagonists. |
Merck Research Laboratories |
15081035 |
24 |
Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4. |
Merck Research Laboratories |
15081033 |
21 |
Amidines as amide bond replacements in VLA-4 antagonists. |
Merck Research Laboratories |
14667228 |
3 |
Synthesis and structure-activity relationship of mannose-based peptidomimetics selectively blocking integrin alpha4beta7 binding to mucosal addressin cell adhesion molecule-1. |
Technische UniversitäT MüNchen |
12617914 |
116 |
N-(3-phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists. |
Merck Research Laboratories |
12270174 |
34 |
Solid-phase synthesis of dual alpha4beta1/alpha4beta7 integrin antagonists: two scaffolds with overlapping pharmacophores. |
Genentech |
12127538 |
26 |
N-aryl-prolyl-dipeptides as potent antagonists of VLA-4. |
Merck Research Laboratories |
12127523 |
22 |
N-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists. |
Merck Research Laboratories |
12031329 |
110 |
Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists. |
Merck Research Laboratories |
11844689 |
51 |
Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists. |
Merck Research Laboratories |
11755344 |
47 |
The discovery of small molecule carbamates as potent dual alpha(4)beta(1)/alpha(4)beta(7) integrin antagonists. |
Merck Research Laboratories |
11755338 |
24 |
Specific and dual antagonists of alpha(4)beta(1) and alpha(4)beta(7) integrins. |
Merck Research Laboratories |
11677134 |
42 |
Design and synthesis of potent and selective inhibitors of integrin VLA-4. |
Novartis Institute For Biomedical Research |
11591507 |
79 |
The discovery of sulfonylated dipeptides as potent VLA-4 antagonists. |
Merck Research Laboratories |
11472212 |
6 |
Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists. |
Technische UniversitäT MüNchen |
10915035 |
16 |
Cell adhesion antagonists: synthesis and evaluation of a novel series of phenylalanine based inhibitors. |
Millennium Pharmaceutical |
10853677 |
34 |
Discovery and evaluation of potent, tyrosine-based alpha4beta1 integrin antagonists. |
Celltech Chiroscience |
10072689 |
39 |
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses. |
Biogen |
16495061 |
8 |
Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agent. |
Johnson & Johnson Pharmaceutical |
16112583 |
74 |
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists. |
Johnson & Johnson Pharmaceutical |
16722660 |
60 |
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists. |
Johnson & Johnson Pharmaceutical |